Ore from a silver mine
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Polymetals Resources Ltd (ASX:POL) has achieved all the needed funding to allow for a restart of the Endeavour silver-zinc-lead mine in central New South Wales, completing formal documentation for its US$20 million Pre-payment Loan Facility with Ocean Partners.

One part of the Facility included the issuing of $2,500,000 options, priced at $1.00 each.

With the papers signed, Polymetals can now access the funds and meet its own redevelopment capital requirements to recommence mining from Endeavor, with first
cashflow on track for the first half of 2025.

Executive chairman Dave Sproule said that confirmation of funding was an important milestone in achievement of a restart for Endeavour – which is located in NSW’s Cobar Basin.

“The Company continues to meet its stated objectives on time, with its senior management in place focussed on the re-development work required to bring Endeavor back online,” he said.

“We are very much looking forward to generating first concentrates and cash flow during H1 2025.”

Polymetals has been trading at 69 cents.

Join the discussion: See what HotCopper users are saying about Polymetals and be part of the conversations that move the markets.

POL by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Financials lead index higher after Trump inauguration | January 21, 2025

The local index clawed back losses throughout the afternoon as investors reacted to Trump’s impending decisions…
The Market Online Video

‘Where there’s risk, there’s reward’: Stab on asset manager the year’s first Hot Stock tip

Wealth Within senior analyst Fil Tortevski and analyst Pedro Banales have named their first HotCopper Hot Stock tip of the year,
REIT concept

Trump is banning work-from-home for Federal workers. Could our REIT index see contagion upside?

To answer the question at the top of the article, any benefit for Australian REIT stocks posed by Trump’s decision to ban work-from-home
Image of clinical researcher making notes

‘Significant’ new milestone for Recce in clinical testing of skin infection gel

Recce Pharmaceuticals Ltd has seen its share price rise more than 1% as it completes dosing…